Status:
COMPLETED
Acceptability and Feasibility Study of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools
Lead Sponsor:
University College, London
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In England, more than three hundred thousand people are diagnosed with cancer each year. The diagnostic and treatment pathways for multiple cancers have greatly developed over the past decade. However...
Detailed Description
This trial is a prospective tissue collection of renal cell carcinoma samples, including collection of data using both structured Likert 12 item questionnaires and semi structured interviews to assess...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years old), of either gender, able to provide consent;
- Suspected or confirmed renal cell carcinoma;
- Signed informed consent by patient
Exclusion
- Non-English speaker;
- Inability to provide informed consent
Key Trial Info
Start Date :
January 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03300102
Start Date
January 10 2018
End Date
December 31 2018
Last Update
January 24 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Surgical & Interventional Trials Unit
London, United Kingdom, NW12BX
2
Royal Free Hospital
London, United Kingdom, NW3 2QG